Cardinal Health, Inc. $CAH Shares Sold by Beck Bode LLC

Beck Bode LLC lessened its stake in Cardinal Health, Inc. (NYSE:CAH) by 8.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 115,133 shares of the company’s stock after selling 10,056 shares during the period. Cardinal Health comprises approximately 3.9% of Beck Bode LLC’s portfolio, making the stock its 2nd largest position. Beck Bode LLC’s holdings in Cardinal Health were worth $23,660,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Strategy Asset Managers LLC acquired a new stake in Cardinal Health in the 3rd quarter valued at approximately $775,000. Mirae Asset Global Investments Co. Ltd. increased its holdings in Cardinal Health by 15.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock valued at $5,938,000 after purchasing an additional 5,030 shares during the last quarter. Versor Investments LP acquired a new stake in Cardinal Health in the 3rd quarter valued at approximately $2,090,000. Machina Capital S.A.S. increased its holdings in Cardinal Health by 248.0% in the 3rd quarter. Machina Capital S.A.S. now owns 27,054 shares of the company’s stock valued at $4,246,000 after purchasing an additional 19,280 shares during the last quarter. Finally, Atle Fund Management AB increased its holdings in Cardinal Health by 13.1% in the 3rd quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock valued at $4,755,000 after purchasing an additional 3,500 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.1%

Cardinal Health stock opened at $200.42 on Friday. The stock has a market cap of $46.94 billion, a P/E ratio of 30.64, a price-to-earnings-growth ratio of 1.19 and a beta of 0.53. The company has a fifty day simple moving average of $205.21 and a 200-day simple moving average of $208.69. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the company earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.19%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on CAH shares. Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a report on Friday, May 1st. Mizuho lifted their target price on shares of Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a report on Friday, February 6th. Citigroup dropped their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. Barclays raised their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. Finally, Evercore decreased their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.